Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Myeloproliferative Disorders 5Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Neutrophilic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia 1Hematologic Neoplasms 1Blast Crisis 1

Interventions

Cyclophosphamide 59Peripheral Blood Stem Cell Transplantation 51fludarabine phosphate 47Busulfan 39Tacrolimus 38Methotrexate 35Mycophenolic Acid 31Filgrastim 30Cyclosporine 30Cytarabine 29Whole-Body Irradiation 28Antilymphocyte Serum 28Radiotherapy 22Methylprednisolone 18Etoposide 18Melphalan 17Cord Blood Stem Cell Transplantation 17Imatinib Mesylate 13Flow Cytometry 13Thiotepa 11Therapeutics 11merphos 10fludarabine 10Granulocyte Colony-Stimulating Factor 10Sirolimus 8Rituximab 8Psychiatric Rehabilitation 8Prednisone 8sargramostim 7Dexamethasone 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Blast Crisis × fedratinib × Clear all
NCT05524857 2024-04-23

Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)

Columbia University

Phase 1 Terminated
2 enrolled
Myeloid

Blast Crisis, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡